NANJING VAZYME BIOTECHNANJING VAZYME BIOTECHNANJING VAZYME BIOTECH

NANJING VAZYME BIOTECH

No trades
See on Supercharts

688105 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Nanjing Vazyme Biotech Co., Ltd. engages in the research and development, and production of antibody drugs. Its products include Biological reagents and In vitro diagnostic products. The biological reagents products consist of polymerase chain reaction series, molecular cloning series, reverse record series, gene sequencing series, bio-assay series, and cell and protein series. The In vitro diagnostic products encompass point-of-care testing diagnostic reagents and instrument. The company was founded on March 16, 2012 and is headquartered in Nanjing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688105 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company